Rifinah, comprimés enrobés

7680389310162 CH-38931 Tabletten
Rifinah, comprimés enrobés
Rifinah, comprimés enrobés
Rifinah, comprimés enrobés
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/12/2024
Patient information leaflet
Français
30/12/2024
Patient information leaflet
Italien
30/12/2024
Summary of Product Characteristics
Allemand
06/12/2024
Summary of Product Characteristics
Français
06/12/2024
Summary of Product Characteristics
Italien
06/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
110.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK
(N/A)
2.28 MG Substance HBESI

Reimbursement information

Public price
CHF 58.40
Specialties list
Yes
Generic
No
SL addition date: 15/03/1976

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
38931
Drug name
Rifinah, comprimés enrobés
Galenic form
DRAG
ATC Code
J04AM02
Authorization status
Z
Dispensing category
A
First authorization
18/09/1975
Authorization expiration date
31/12/9999
IT Number
08.02.2.
Domain
Human medicine

Package details

Description (FR)
RIFINAH drag 150/100 mg 100 pce
Description (DE)
RIFINAH Drag 150/100 mg 100 Stk
Market launch
18/09/1975
Narcotic (BTM)
No